Loading...

Cellectar Biosciences, Inc.

CLRB•NASDAQ
Healthcare
Biotechnology
$3.44
$0.75(28.07%)
U.S. Market is Open • 15:21

Cellectar Biosciences, Inc. (CLRB) Stock Overview

Explore Cellectar Biosciences, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap9M
P/E Ratio-0.55
EPS (TTM)$-8.35
ROE-2.49%
Fundamental Analysis

AI Price Forecasts

1 Month$2.37
3 Months$3.88
1 Year Target$5.16

CLRB Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Cellectar Biosciences, Inc. (CLRB) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 51.62, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $5.16.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.55 and a market capitalization of 9M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
5.20%
5-Day Change
7.20%
1-Month Change
4.43%
3-Month Change
-5.35%
6-Month Change
-15.52%
Year-to-Date (YTD) Change
-4.07%
1-Year Change
-64.54%
3-Year Change
-93.63%
5-Year Change
-99.38%
All-Time (Max) Change
-100.00%

Contact Information

https://www.cellectar.com
608 441 8120
100 Campus Drive, Florham Park, NJ, 07932

Company Facts

11 Employees
IPO DateNov 10, 2005
CountryUS
Actively Trading

Frequently Asked Questions